How antiviral pill molnupiravir shot ahead in the COVID drug hunt

The Merck pill, which could become the first oral antiviral COVID treatment, forces the SARS-CoV-2 coronavirus to mutate itself to death.
By
  1. Cassandra Willyard
    View author publications

    You can also search for this author in PubMed  Google Scholar

Access through your institution
Buy or subscribe

The pharmaceutical firm Merck announced last week that an antiviral pill it’s developing can cut hospitalizations and deaths among people with COVID-19 by half. The results haven’t yet been peer reviewed. But if the drug candidate, molnupiravir, is authorized by regulators, it would be the first oral antiviral treatment for COVID-19. By contrast, the other currently authorized drugs must be delivered intravenously or injected.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-021-02783-1

Updates & Corrections

  • Clarification 09 October 2021: This story was updated to clarify that the two Indian drugmakers testing a generic version of molnupiravir did so independently of Merck, and to add comments from Merck indicating that moderate cases of COVID-19 in India are defined as being more severe than those in the United States.

References

  1. Beigel, J. H. et al. N. Engl. J. Med. 383, 1813-1826 (2020).

    Google Scholar 

  2. Sheahan, T. P. et al. Sci. Transl. Med. 12, eabb5883 (2020).

    Google Scholar 

  3. Cox, R. M. et al. Nature Microbiol. 6, 11-18 (2021).

    Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

  • Assistant Professor

    The Department of Pathology in the Wayne State University School of Medicine (https://pathology.med.wayne.edu/) is expanding its high-impact resear...

    Detroit, Michigan

    Wayne State Universtiy

  • Professor - Leading Scientist in Healthcare and Biomedical Sciences

    United Arab Emirates University (UAEU), in collaboration with the College of Medicine and Health Sciences (CMHS)

    United Arab Emirates (AE)

    UAEU

  • Postdoctoral Researcher

    Research on exploration of physics and device application using dielectric materials, ionic conductors, and magnetic materials based on transport...

    Tsukuba, Ibaraki (JP)

    National Institute for Materials Science (NIMS)

  • JUNIOR RESEARCH GROUP LEADER IN LIFE SCIENCES

    RESEARCH GROUP LEADER IN LIFE SCIENCES

    Czech Republic (CZ)

    Central European Institute of Technology (CEITEC)

  • PhD positions in Aging Research

    Work time part-time   Start date 01.06.2025   Employment period limited   Application deadline 30.04.2025 Deployment location Charité Campus Charit...

    Berlin (DE)

    Charité – Universitätsmedizin Berlin

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing